Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.36 |
| ▸ | TTR | P02766 | 2/20 | 0.36 |
| ▸ | ALB | P02768 | 2/20 | 0.36 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MMP3 | P08254 | 1/20 | 0.34 |
| ▸ | VCAM1 | P19320 | 2/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18301559 | 0.95 | KDM4E (0.43) | KDM4ETDP1ENPP2TTRALB | |
| SCHEMBL1484452 | 0.84 | KDM4E (0.37) | KDM4ETDP1ENPP2TTRALB | |
| SCHEMBL501516 | 0.84 | CYP2A6 (0.38) | KDM4ETDP1ENPP2TTRALB | |
| SCHEMBL501685 | 0.84 | KDM4E (0.41) | KDM4ETDP1VCAM1 | |
| SCHEMBL25990556 | 0.84 | KDM4E (0.37) | KDM4ETDP1CYP11B1CYP11B2 | |
| SCHEMBL4007007 | 0.80 | KDM4E (0.52) | KDM4ETDP1ENPP2MEN1KMT2A | |
| SCHEMBL24108532 | 0.80 | RXRA (0.46) | KDM4ETDP1MEN1KMT2A | |
| SCHEMBL1542913 | 0.78 | LOXL2 (0.41) | TTRALBLOXL2CYP2A6MEN1 | |
| SCHEMBL3063453 | 0.77 | ENPP2 (0.53) | KDM4ETDP1ENPP2MEN1KMT2A | |
| SCHEMBL6958311 | 0.77 | KDM4E (0.34) | KDM4ETDP1ENPP2LOXL2CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4646086-A2 | ORGANIC LIGHT EMITTING DISPLAY DEVICE | LG Display Co., Ltd. (KR) | 2025-11-05 | — | — | EP | disclosed |
| EP-4009392-B1 | ORGANIC LIGHT EMITTING DISPLAY DEVICE | LG DISPLAY CO LTD (KR) | 2025-11-05 | — | — | EP | disclosed |
| WO-2024126528-A1 | ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING A COMPOUND OF FORMULA (I) AND A COMPOUND OF FORMULA (II), AND DISPLAY DEVICE COMPRISING THE ORGANIC ELECTROLUMINESCENT DEVICE | NOVALED GMBH (DE) | 2024-06-20 | — | — | WO | disclosed |
| CN-115677731-B | Organic compound and application thereof in organic electronic device | 广州追光科技有限公司 | 2024-04-16 | — | — | CN | disclosed |
| CN-112390784-B | Organic compound, organic light emitting diode including the same, and organic light emitting display device | 乐金显示有限公司 | 2024-02-20 | — | — | CN | disclosed |
| US-11889754-B2 | Organic compound, and organic light emitting diode and organic light emitting display device including the same | LG DISPLAY CO., LTD (KR) | 2024-01-30 | — | — | US | disclosed |
| US-11877507-B2 | Organic light emitting display device | LG DISPLAY CO., LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| US-11877507-B2 | Organic light emitting display device | LG DISPLAY CO., LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| WO-2023232967-A1 | ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING A COMPOUND OF FORMULA (I) AND A COMPOUND OF FORMULA (II), AND DISPLAY DEVICE COMPRISING THE ORGANIC ELECTROLUMINESCENT DEVICE | NOVALED GMBH (DE) | 2023-12-07 | — | — | WO | disclosed |
| US-20230389415-A1 | Organic Light Emitting Display Device | LG DISPLAY CO., LTD. (KR) | 2023-11-30 | — | — | US | disclosed |
| EP-3176844-A1 | ORGANIC LIGHT EMITTING DISPLAY DEVICE | LG Display Co., Ltd. (KR) | 2017-06-07 | — | — | EP | disclosed |
| US-8106064-B2 | administering 1-[2-Chloro-6-(4-methoxy-benzylamino)-pyridin-4-ylmethyl]-6-(3-[1,3]dioxolan-2-yl-5-methyl-phenoxy)-5-isopropyl-1H-pyrimidine-2,4-dione viricide to treat AIDS | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2012-01-31 | — | — | US | disclosed |
| US-8106064-B2 | administering 1-[2-Chloro-6-(4-methoxy-benzylamino)-pyridin-4-ylmethyl]-6-(3-[1,3]dioxolan-2-yl-5-methyl-phenoxy)-5-isopropyl-1H-pyrimidine-2,4-dione viricide to treat AIDS | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2012-01-31 | — | — | US | disclosed |
| US-20100034827-A1 | NOVEL HIV REVERSE TRANSCRIPTASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2010-02-11 | — | — | US | disclosed |
| US-20100034827-A1 | NOVEL HIV REVERSE TRANSCRIPTASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2010-02-11 | — | — | US | disclosed |
| EP-2044037-A2 | HIV REVERSE TRANSCRIPTASE INHIBITORS | Gilead Sciences, Inc. (US) | 2009-04-08 | — | — | EP | disclosed |
| US-20080070920-A1 | Novel HIV reverse transcriptase inhibitors | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2008-03-20 | — | — | US | disclosed |
| US-20080070920-A1 | Novel HIV reverse transcriptase inhibitors | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2008-03-20 | — | — | US | disclosed |
| WO-2008016522-A2 | HIV REVERSE TRANSCRIPTASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2008-02-07 | — | — | WO | disclosed |
| WO-2008016522-A2 | HIV REVERSE TRANSCRIPTASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2008-02-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11877507-B2 | Organic light emitting display device | ALDH1A1, AOX1, ALDH1A2 | KDM4E 3706/4885TDP1 1429/4885ENPP2 4082/4885 |
| US-20100034827-A1 | NOVEL HIV REVERSE TRANSCRIPTASE INHIBITORS | POLR2E, POLRMT, POLR2H | KDM4E 1269/4885TDP1 143/4885ENPP2 1664/4885 |
| US-11889754-B2 | Organic compound, and organic light emitting diode and organic light emitting display device including the same | OCIAD1, OCIAD2, AOX1 | KDM4E 3167/4885TDP1 1312/4885ENPP2 2822/4885 |
| US-20080070920-A1 | Novel HIV reverse transcriptase inhibitors | POLR2E, POLRMT, POLR2H | KDM4E 1234/4885TDP1 147/4885ENPP2 1679/4885 |
| US-20230389415-A1 | Organic Light Emitting Display Device | ALDH1A1, ALDH1A2, OCIAD1 | KDM4E 3767/4885TDP1 1287/4885ENPP2 4359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.